Estrella Immunopharma (ESLA)
NASDAQ:ESLA
US Market
Holding ESLA?
Track your performance easily

Estrella Immunopharma (ESLA) Income Statement

22 Followers

Estrella Immunopharma Income Statement

Last quarter (Q ), Estrella Immunopharma's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Estrella Immunopharma's net income was $-469.53K. See Estrella Immunopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 24Dec 22Dec 21
Total Revenue
-$ 50.00K--
Cost of Revenue
----
Gross Profit
-$ 50.00K--
Operating Expense
$ 2.50M$ 7.31M$ 1.37M$ 178.99K
Operating Income
$ -2.51M$ -7.31M$ -1.57M$ -249.15K
Net Non Operating Interest Income Expense
---$ 1.43K
Other Income Expense
$ -114.31K-$ -654.07K$ -1.43K
Pretax Income
$ -2.39M$ -7.31M$ -915.46K$ -247.72K
Tax Provision
$ 21.08K$ 1.63K$ 80.65K-
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -2.42M$ -7.31M$ -1.25M$ -107.41K
Basic EPS
$ -1.81$ -0.27$ -0.22$ -1.52
Diluted EPS
$ -1.81$ -0.27$ -0.22$ -1.52
Basic Average Shares
$ 38.90M$ 27.10M$ 4.34M$ 1.18M
Diluted Average Shares
$ 38.98M$ 27.10M$ 4.34M$ 1.18M
Dividend Per Share
$ 2.00$ 1.00--
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 1.56M$ 7.31M$ 1.37M$ 178.99K
Net Income From Continuing And Discontinued Operation
$ -2.42M$ -7.31M$ -996.10K$ -247.72K
Normalized Income
$ -1.48M$ -5.77M-$ -195.70K
Interest Expense
----
EBIT
$ -1.46M$ -7.31M$ -915.46K$ -247.72K
EBITDA
$ -1.46M$ -7.31M$ -915.46K$ -247.72K
Currency in USD

Estrella Immunopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis